Apmonia Therapeutics
Develops peptide-based cancer therapies targeting the tumor microenvironment for patients with cancer
Highlights
- New on EvolcAdded 2026-11-02
About Apmonia Therapeutics
Apmonia Therapeutics develops peptide-based therapies targeting the tumor microenvironment, with a focus on immuno-oncology. Its lead program, AP-01, is a cyclic peptide targeting TSP-1; other programs target extracellular matrix components.
The company was founded in 2019 as a spin-off of CNRS and Reims University. Its registered headquarters are in Reims, France.
Product: A pipeline of peptide-based cancer therapies targeting the tumor microenvironment and extracellular matrix.
Jobs at Apmonia Therapeutics
Leadership
- Albin JEANNE · PresidentSource: company website
More biotech & pharma companies
Aqemia
AI drug discovery company using physics-based algorithms and generative AI to design and optimise drug moleculesNew on EvolcRemote-friendlyAtlantic Bone Screen
Preclinical contract research services for pharmaceutical, biotech, biomaterials and nutraceutical developersNew on EvolcBforcure
Point-of-need microorganism analysis instruments and PCR design software for medical, food, water and agriculture labsNew on EvolcBgene Genetics
Co-develops bio-based, low-carbon ingredients through synthetic biology for aroma, fragrance, food and cosmetics makersNew on EvolcBiorea
Contract culture of microorganisms and biomass, from bench to fermenter, plus bioreactors for R&D and scale-up projectsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Backend
- PHPHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-powered-by
- Response headerx-powered-by
- Response headerx-powered-by
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Contact Form 7High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.